Basf India Limited · NSE:BASF
Basf India — Investor Presentation (November 2022)
16 slides from Basf India's investor presentation, Nov 18, 2022
Slide 1: Cover letter to exchanges on analysts meeting
BASF India Limited, Mumbai - 400 051, India November 18, 2022 The Market Operations Department BSE Limited, Phiroze Jeejeebhoy Towers Dalal Street, Mumbai 400 001 Name of the Company : BASF INDIA LIMITED Security Code No. : 500042 Dear Sir/Madam, Re: Analysts / Fund Managers Meeting of BASF India Li
Slide 2: Analysts / Fund Managers Meeting BASF India Limited
Analysts / Fund Managers Meeting BASF India Limited Narayan Krishnamohan Managing Director Narendranath J. Baliga Chief Financial Officer Mumbai, 18.11.2022
Slide 3: Forward looking statements
Forward looking statements… Only matters in the public domain can be subject matter of discussion in this meeting As a matter of policy, we do not provide any forecast about the future business situation We do not comment or give guidance on future results or business outlook
Slide 4: Safety is first priority, always
Safety is first priority, always 2021 2022 Comparison Jan - Oct Jan - Oct (-) (+) Work Related Injuries FAT 0 0 Work Related Injuries LTI 5 6 BASF + Leasing employees + per 200,000 hours* 0.07 0.09 Contractors worked First Aid Cases First aid 17 18 RDI 3 1 Near Miss 173 157 Reportable AR Accidental
Slide 5: Geopolitics and Inflation hold sway over FY 23 GDP
Geopolitics and Inflation hold sway over FY 23’ GDP Automotive: PV best year in decade (FADA- Nov 22’); Improved semiconductor supply, inventory buildup positively influence India wholesale auto (LCMA- Oct 22’) Construction: Demand appetite rebounding in tier 2-3 cities, retail & commercial real est
Slide 6: Our Financial Performance
Our Financial Performance Internal
Slide 7: Segment Revenue breakup
Segment Revenue breakup In Rs. Crs Apr to Sep 2022 Others 55 (1%) Agricultural Solutions 1,122 (15%) Chemicals 1,255 (17%) Agricultural Materials Industrial Solutions Performance Materials Solutions Monomers Dispersions Nutrition & Care Performance 1,417 (19%) Chemicals Total 7,470 Materials 2,007 (
Slide 8: Financial performance
Financial performance In Rs. Crs QoQ Half Yearly (YoY) +5% -19% +16% -4% 3,582 183 7,470 432 3,405 413 6,418 149 Jul- Jul- Jul- Jul- Apr- Apr- Apr- Apr- Sep 21 Sep 22 Sep’21 Sep’22 Sep’21 Sep’22 Sep’21 Sep’22 Revenue PBT bEI Revenue PBT bEI Revenue driven by volumes growth coupled with better realis
Slide 9: Quarter on Quarter Development
Quarter on Quarter Development In Rs. Crs Revenue from Operations PBT before Exceptional Items -19% 264 248 +5% 3,888 197 3,582 183 179 171 3,405 3,292 3,390 137 149 3,013 111 2,805 2,460 2,507 35 1,892 1,786 -41 M’20 J’20 S’20 D’20 M’21 J’21 S’21 D’21 M’22 J’22 S’22 M’20 J’20 S’20 D’20 M’21 J’21 S’
Slide 10: Revenue development by segment
Revenue development by segment In Rs. Crs Apr to Sep 2022 7,470 23 2 265 41 183 399 6,418 185 Revenue Agricultural Materials Industrial Surface Nutrition Chemicals Others Revenue Apr - Sep 21 Solution Solutions Technologies & Care Apr - Sep 22 Revenue Apr - Sep 22 (abs.) 1,122 2,007 1,285 329 1,417
Slide 11: PBT bEI development by segment
PBT bEI development by segment In Rs. Crs Apr to Sep 2022 432 71 90 44 43 413 1 12 14 PBT bEI Agricultural Materials Industrial Surface Nutrition Chemicals Others, PBT bEI Apr - Sep 21 Solution Solutions Technologies & Care Unallocated Apr - Sep 22 & Interest PBT bEI Apr - Sep 22 (abs.) 159 110 89 (
Slide 12: Key Performance Indicators
Key Performance Indicators H1 Financial H1 Financial 22-23 Year 22-23 Year 21-22 21-22 Receivable Operating 65 63 65 7.2% 7.7% 8.2% 7.4% Days Exps. (%) Inventory EBIT bEI 60 58 5.6% 5.0% 5.8% Days (%) EPS bEI* Current Ratio 1.8 1.4 135.2 71.6 58.6 135.2 (in abs. Rs) Net Working Capital 9.1% 8.3% ROC
Slide 13: Sustained growth projects with investments and new utilities
Sustained growth projects with investments and new utilities Manufacturing R&D Utility Dispersions capacity Groundbreaking for new Power Control Centre doubled, production Polyurethane Application and DM Water Plant begins Development Lab inaugurated DAHEJ THANE MANGALORE
Slide 14: Sustaining growth with continued customer and stakeholder connect
Sustaining growth with continued customer and stakeholder connect 250+ doctors participated under Continued At IndiaChem 22’ participation in CEO Medical Education webinar by IMA & BASF Roundtable & inaugural session on chemicals BASF Care Chemicals & Intermediates team Drug Release Design – Forum f
Slide 15: Endeavor - sustainable and profitable growth
Endeavor - sustainable and profitable growth Operational Customer Networks Efficiency and efficiencies & Engagement Talent Geopolitics & supply chain Topline growth Leverage NPS for customer Future of work @BASF disruption focus Margin Management Talent Development Drive industry voice a
Slide 16: Internal
O- BASF We create chemistry